September 2025
The biological sample temperature-controlled storage services market is on an upward trajectory, poised to generate substantial revenue growth, potentially climbing into the hundreds of millions over the forecast years from 2025 to 2034. This surge is attributed to evolving consumer preferences and technological advancements reshaping the industry.
Due to growing diseases and R&D activities, the demand for biological sample temperature-controlled storage services is increasing globally, where they are being used to store diagnostic samples or biological samples for research. AI is being used to ensure the stable and controlled temperature throughout their storage, where the companies and government are also investing, and providing new initiatives. Additionally, the expanding healthcare sector, new launches, and developments are also increasing their use in various regions, promoting the market growth.
The biological sample temperature-controlled storage services market is driven by the growing need for reliable preservation of sensitive biological material for research, therapeutics, and diagnostics. The biological sample temperature-controlled storage services include services and infrastructure for preserving biological materials under controlled temperature conditions to ensure sample integrity, stability, and viability. It covers storage of samples such as blood, tissues, DNA, RNA, cell lines, and other biomaterials used in research, diagnostics, biobanking, clinical trials, and pharmaceutical development.
The use of AI in the biological sample temperature-controlled storage services market is increasing as it is being used in the development of various types of sensors and IoT equipment. This, in turn, helps in real-time tracking and monitoring of environmental conditions, as well as the temperature fluctuations, which in turn ensure the samples are stored in the required temperature ranges. Additionally, alerts are also provided for the slightest deviation to avoid the spoiling or degradation of the samples.
Expanding biobanks: Due to growing diseases and research and development, the demand for biological samples is increasing, leading to the expansion of biobanks. At the same time, the growing technological innovations are increasing the focus on temperature-controlled storage solutions for the biobanks. Moreover, the government initiatives and investments are supporting these advancements, enhancing the biological sample temperature-controlled storage services market growth.
For instance,
Company | Innovations | Role | Source |
Cache DNA | Biomolecule preservation technologies | Preserve biomolecules at room temperature | This MIT spinout is taking biomolecule storage out of the freezer – MIT Department of Chemistry |
METHER | A series of medical-grade refrigerators | Precise storage of vaccines, pharmaceuticals, and biological materials | METHER Launches New Line of Medical Refrigerators with Enhanced Temperature Stability-metherbiomedical.com |
SCHOTT Pharma | SCHOTT TOPPAC® (freeze polymer syringes) | Protect medications at temperatures as low as -180 °C and promote the storage of sensitive biologics, like cell and gene therapies | MEDIA RELEASE | Protecting precious therapies: SCHOTT Pharma unveils polymer syringe for ultra-low temperature storage at -180 °C |
By application type, the pharmaceutical industry segment held the dominating share of approximately 40% in the biological sample temperature-controlled storage services market in 2024, due to growing drug discovery and development. At the same time, the rise in the biologics development also increased the demand for biological samples. Similarly growing demand for cell and gene therapies also contributed to the same.
By application type, the clinical trials segment is expected to show the highest growth during the predicted time. The growth in the development of personalized medicines is increasing the clinical trials, driving the demand for biological sample storage services. Additionally, the growing trials on oncology and rare diseases, along with increasing outsourcing trends, are driving the demand for temperature-controlled storage services.
By storage type, the ultra-low temperature storage segment led the biological sample temperature-controlled storage services market with approximately 45% share in 2024, driven by increased development of advanced therapies. They were also used to store various biological samples to maintain their integrity. Moreover, they also ensured the sample storage and stability for long-term which increased their use for R&D.
By storage type, the low temperature storage segment is expected to show the fastest growth rate during the upcoming years. They are being preferred for the storage of vaccines, blood, and plasma samples. This, in turn, is increasing their use in molecular diagnostics as well as infectious disease testing.
By end user, the research laboratories segment held the largest share of approximately 35% in the global biological sample temperature-controlled storage services market in 2024, due to growing research and development activities. This increased the demand for stable and long-term biological sample storage solutions. Moreover, the growing use of protein, cells, and tissues has also increased their use.
By end user, the biotech & pharmaceutical companies segment is expected to show the highest growth during the forthcoming years. The growth in R&D investments and clinical trials is increasing the use of biological sample temperature-controlled storage services. Additionally, they are also utilizing specialized services and tools for the storage of biologics, therapies, and other biosimilars.
North America dominated the biological sample temperature-controlled storage services market with 40% in 2024, due to the presence of advanced industries, which increased the use of temperature-controlled storage services for the storage of various biological products. The expanding biobanks and growing research activities have also increased their use. Additionally, the healthcare investment also encouraged their use, which contributed to the market growth.
The presence of biotech and pharmaceutical hubs in the U.S. is increasing the use of biological sample temperature-controlled storage services due to growing drug development. The increasing R&D investments and clinical trials are also increasing their use, where the growing number of hospitals and clinics are also increasing their demand. The companies are developing new temperature-controlled storage technologies.
For instance,
The growing number of startups, along with the research institutions, is contributing to the increased R&D activities, increasing the use of biological sample temperature-controlled storage services in Canada. Additionally, the growing government initiatives and biobank networks are supporting their clinical trials, where the demand for biological sample storage services is increasing.
According to the Canadian Health Measures Survey, types of biological samples and their volume stored in the biobanks include serum with 0.5ml, plasma with 0.5ml, whole blood with 1.0ml, urine with 1.0, 2.0, and 4.5ml, and DNA with 1 µg.
Asia Pacific is expected to host the fastest-growing biological sample temperature-controlled storage services market during the forecast period. The expanding healthcare infrastructure and industries are increasing the use of biological sample temperature-controlled storage services. Similarly, the growing clinical trials is also increasing their use, where the government is also providing its support by making the services more affordable. Thus, this is promoting the market growth.
The development of energy-efficient, sustainable, and automated systems, as well as advanced software for sample tracking and data integration supporting high-throughput research, is the main focus in the R&D of biological sample temperature-controlled storage services
Key Players: Thermo Fisher Scientific Inc., Azenta Life Sciences, Sartorius AG, Cryoport Inc., Avntor Inc.
The clinical trials and regulatory approval of the biological sample temperature-controlled storage services include strict adherence to Good Laboratory Practice (GLP) and Good Clinical Practice (GCP).
Key Players: Thermo Fisher Scientific Inc., Azenta Life Sciences, LabCrop, Cryoport Inc., Avantor Inc.
The packaging and serialization of the biological sample temperature-controlled storage services involve a strong, multilayer system to prevent sample contamination and leakage, and a unique ID with 2D barcodes for end-to-end traceability.
Key Players: Thermo Fisher Scientific Inc., Azenta Life Sciences, LabCrop, Cryoport Inc., Avantor Inc., Charles River Laboratories.
The distribution to hospitals and pharmacies in the biological sample temperature-controlled storage services involves the use of a cold chain with specialized courier services, strict chain of custody protocols, and advanced packaging with temperature monitors, to maintain the sample integrity.
Key Players: Thermo Fisher Scientific Inc., Azenta Life Sciences, LabCrop, Cryoport Inc., Avantor Inc., Charles River Laboratories.
The patient support and services of the biological sample temperature-controlled storage services focus on providing transparent communication, safeguarding patient privacy, data rights, and ensuring informed consent throughout the sample collection and storage for R&D purposes.
Key Players: Thermo Fisher Scientific Inc., Azenta Life Sciences, LabCrop, Cryoport Inc., Avantor Inc., Charles River Laboratories.
By Application
By Storage Type
By End-User
By Region
According to market projections, the global anticancer drugs market, valued at USD 167.09 billion in 2024, is anticipated to reach USD 401.32 billion ...
September 2025
September 2025
August 2025
July 2025